Age, Biography and Wiki

Carolyn R. Bertozzi (Carolyn Ruth Bertozzi) was born on 10 October, 1966 in Boston, Massachusetts, U.S., is an American chemist (born 1966). Discover Carolyn R. Bertozzi's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is she in this year and how she spends money? Also learn how she earned most of networth at the age of 57 years old?

Popular As Carolyn Ruth Bertozzi
Occupation N/A
Age 57 years old
Zodiac Sign Libra
Born 10 October 1966
Birthday 10 October
Birthplace Boston, Massachusetts, U.S.
Nationality United States

We recommend you to check the complete list of Famous People born on 10 October. She is a member of famous with the age 57 years old group.

Carolyn R. Bertozzi Height, Weight & Measurements

At 57 years old, Carolyn R. Bertozzi height not available right now. We will update Carolyn R. Bertozzi's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

She is currently single. She is not dating anyone. We don't have much information about She's past relationship and any previous engaged. According to our Database, She has no children.

Family
Parents Not Available
Husband Not Available
Sibling Not Available
Children Not Available

Carolyn R. Bertozzi Net Worth

Her net worth has been growing significantly in 2023-2024. So, how much is Carolyn R. Bertozzi worth at the age of 57 years old? Carolyn R. Bertozzi’s income source is mostly from being a successful . She is from United States. We have estimated Carolyn R. Bertozzi's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income

Carolyn R. Bertozzi Social Network

Instagram
Linkedin
Twitter Carolyn R. Bertozzi Twitter
Facebook
Wikipedia Carolyn R. Bertozzi Wikipedia
Imdb

Timeline

1966

Carolyn Ruth Bertozzi (born October 10, 1966) is an American chemist and Nobel laureate, known for her wide-ranging work spanning both chemistry and biology.

She coined the term "bioorthogonal chemistry" for chemical reactions compatible with living systems.

Her recent efforts include synthesis of chemical tools to study cell surface sugars called glycans and how they affect diseases such as cancer, inflammation, and viral infections like COVID-19.

At Stanford University, she holds the Anne T. and Robert M. Bass Professorship in the School of Humanities and Sciences.

Bertozzi is also an Investigator at the Howard Hughes Medical Institute (HHMI) and is the former director of the Molecular Foundry, a nanoscience research center at Lawrence Berkeley National Laboratory.

She received the MacArthur "genius" award at age 33.

1988

After graduating from Harvard in 1988, she worked at Bell Labs with Chris Chidsey.

1993

Bertozzi completed her Ph.D. in chemistry at University of California, Berkeley in 1993 with Mark Bednarski, working on the chemical synthesis of oligosaccharide analogs.

While at Berkeley, she discovered that viruses can bind to sugars in the body.

The discovery led to her field of research, glycobiology.

During Bertozzi's third year of graduate school, Bednarski was diagnosed with colon cancer, which resulted in him taking a leave of absence and changing his career path by enrolling in medical school.

This left Bertozzi and the rest of the lab to complete their Ph.D. work with no direct supervision.

After graduating from Berkeley with a Ph.D., Bertozzi was a postdoctoral fellow at University of California, San Francisco (UCSF) with Steven Rosen, where she studied the activity of endothelial oligosaccharides in promoting cell adhesion at inflammation sites.

While working with Rosen at UCSF, Bertozzi was able to modify the protein and sugar molecules in the walls of living cells so that the cells accept foreign materials such as implants.

1996

In 1996 Bertozzi became a faculty member in the UC Berkeley College of Chemistry and a faculty scientist at Lawrence Berkeley National Laboratory, where she served as the director of the Molecular Foundry.

1999

In 1999, while working with HHMI and at Berkeley, she founded the field of bioorthogonal chemistry and coined the term in 2003.

This new field and technique allows researchers to chemically modify molecules in living organisms and not interrupt the processes of the cell.

2000

She has been an investigator with HHMI since 2000.

2001

In 2001, Bertozzi and Steve Rosen co-founded Thios Pharmaceuticals in Emeryville, California, the first company to target sulfation pathways.

2005

She is a member of the National Academy of Sciences (2005), the Institute of Medicine (2011), and the National Academy of Inventors (2013).

Thios Pharmaceuticals dissolved in 2005.

2008

In 2008, Bertozzi founded a startup of her own: Redwood Bioscience also in Emeryville, California.

Redwood Bioscience is a biotechnology company that uses SMARTag, a site-specific protein modification technology that allows small drugs to attach to sites on the proteins and can be used to help fight cancers.

2010

In 2010, she was the first woman to receive the prestigious Lemelson–MIT Prize faculty award.

2014

In 2014, it was announced that Bertozzi would lead ACS Central Science, the American Chemical Society's first peer-reviewed open access journal, which offers all content free to the public.

Since 2021 she has been a member of the Accademia dei Lincei.

As an open lesbian in academia and science, Bertozzi has been a role model for students and colleagues.

Bertozzi was awarded the 2022 Nobel Prize in Chemistry, jointly with Morten P. Meldal and Karl Barry Sharpless, "for the development of click chemistry and bioorthogonal chemistry".

Carolyn Bertozzi received her B.A., summa cum laude, in chemistry from Harvard University, where she worked with Professor Joe Grabowski on the design and construction of a photoacoustic calorimeter.

Grabowski was impressed with her work and required Bertozzi to write a thesis on this project, which was submitted and Bertozzi won the Thomas T. Hoopes Undergraduate Thesis Prize with a large prize money.

While an undergraduate, she played in several bands, notably Bored of Education with future Rage Against the Machine guitarist Tom Morello.

2015

In 2015, Bertozzi moved to Stanford University to join the ChEM-H Institute.

Bertozzi studies the glycobiology of underlying diseases such as cancer, inflammatory disorders such as arthritis, and infectious diseases such as tuberculosis.

In particular, Bertozzi has advanced the understanding of cell surface oligosaccharides involved in cell recognition and inter-cellular communication.

Bertozzi has applied the techniques of bioorthogonal chemistry to study glycocalyx, the sugars that surround the cell membrane.

Her discoveries have advanced the field of biotherapeutics.

Her lab has also developed tools for research.

One such development is creating chemical tools for studying glycans in living systems.

2017

In 2017, due to her lab's discovery of linking the sugars on the surface of cancer cells and their ability to avoid the immune system defenses, she was invited to speak at Stanford's TED talk, giving a talk entitled "What the sugar coating on your cells is trying to tell you".

2018

Her lab's development of nanotechnologies which probe biological systems lead to the development of a fast point-of-care tuberculosis test in 2018.